Finance

Beta
Lists
PALI:NASDAQ
Palisade Bio Inc
$1.96
-0.51%
(-0.0100) 1D
$1.96
0.00% (0.00)
After hours
Closed: Jul 10, 3:55:25 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PALI...
Open
$1.99
High
$1.99
Low
$1.87
Mkt. cap
341.95M
Avg. vol.
4.00M
Volume
2.44M
52-wk high
$2.86
52-wk low
$0.53
EPS
-$1.17
Beta
1.50
Shares outstanding
173.58M
No. of employees
14
Open
$1.99
High
$1.99
Low
$1.87
Mkt. cap
341.95M
Avg. vol.
4.00M
Volume
2.44M
52-wk high
$2.86
52-wk low
$0.53
EPS
-$1.17
Beta
1.50
Shares outstanding
173.58M
No. of employees
14
News stories
From sources across the web
About Palisade Bio Inc
CEO-
Employees14
Founded2005
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websitepalisadebio.com
Analyst ratings
Based on 5 analysts giving stock ratings to PALI in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PALI in the last 3 months.
Highest
Current $1.96
$25.00 (+1,175.51%)
Average
$10.40 (+430.61%)
Lowest
$5.00 (+155.10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$5.00
+155.1%
07/06/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$8.00
+308.2%
06/29/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$7.00
+257.1%
06/30/2026
William Wood
B. Riley Securities
Buy
Reiterated
$7.00
+257.1%
06/02/2026
Yasmeen Rahimi
Piper Sandler
Buy
Reiterated
$25.00
+1,175.5%
04/13/2026
Andy Chen
Wolfe Research
Buy
Initiated
$7.00
+257.1%
04/08/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$12.00
+512.2%
03/31/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.68M
1.39M
6.17M
6.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.17M
1.53M
3.81M
4.35M
Operating expense
2.84M
2.92M
9.98M
10.75M
Total operating expenses
2.84M
2.92M
9.98M
10.75M
Operating income
-2.84M
-2.92M
-9.98M
-10.75M
Other non operating income
61.00K
59.00K
1.08M
1.15M
EBT including unusual items
-2.78M
-2.87M
-8.90M
-9.60M
EBT excluding unusual items
-2.78M
-2.87M
-8.90M
-9.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.78M
-2.87M
-8.90M
-9.60M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.38
-
-0.05
Interest and investment income
-
-
-
-
Interest expense
-2.00K
-5.00K
-2.00K
-1.00K
Net interest expenses
-2.00K
-5.00K
-2.00K
-1.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.84M
-2.92M
-9.98M
-10.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer